Geron fails to overturn stem cell patent ruling in Europe

02/15/2009 | Forbes

The European Patent Office has sustained an earlier decision that invalidates stem cell patents owned by Geron and the Wisconsin Alumni Research Foundation. Geron did not give further details on the ruling, which comes a week after the biotech firm obtained FDA approval to conduct human trials involving stem cells.

View Full Article in:

Forbes

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Confidential
Pompano Beach, FL